Search by Drug Name or NDC
NDC 62135-0022-01 Celecoxib 200 mg/1 Details
Celecoxib 200 mg/1
Celecoxib is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is CELECOXIB.
Product Information
NDC | 62135-0022 |
---|---|
Product ID | 62135-022_00b27899-e68e-e9d9-e063-6394a90a88cb |
Associated GPIs | |
GCN Sequence Number | 041286 |
GCN Sequence Number Description | celecoxib CAPSULE 200 MG ORAL |
HIC3 | S2L |
HIC3 Description | NSAIDS,CYCLOOXYGENASE-2(COX-2) SELECTIVE INHIBITOR |
GCN | 42002 |
HICL Sequence Number | 018979 |
HICL Sequence Number Description | CELECOXIB |
Brand/Generic | Generic |
Proprietary Name | Celecoxib |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Celecoxib |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 200 |
Active Ingredient Units | mg/1 |
Substance Name | CELECOXIB |
Labeler Name | Chartwell RX, LLC |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA211412 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0022-01 (62135002201)
NDC Package Code | 62135-022-01 |
---|---|
Billing NDC | 62135002201 |
Package | 100 CAPSULE in 1 BOTTLE (62135-022-01) |
Marketing Start Date | 2022-11-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |